Anti-Iba1 antibody - Microglia marker

The University of Virginia awarded contract A207_PO-0463578-V3 to Epitomics Inc on August 29, 2026. The prime contractor will deliver anti-Iba1 antibody products, which serve as microglia markers used in research applications. The contract specifies a unit price of one per item ordered, with deliveries to be made to the University of Virginia as the buying organization. The contract is located in Virginia; however, specific performance locations and contract values are not provided in the available documentation.

No additional details regarding cumulative contract value, annual value, specific contract amount, period of performance beyond the award date, or county designation are available from the source materials. The line item structure indicates a purchase order mechanism with potential for multiple unit acquisitions, though the aggregate contract value and delivery schedule have not been specified in this award notice.